Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094)
- 1 June 1990
- journal article
- research article
- Published by Springer Nature in Inflammation Research
- Vol. 30 (3-4) , 443-450
- https://doi.org/10.1007/bf01966310
Abstract
Drugs which block the biosynthesis of leukotrienes and prostaglandins may have potential in the treatment of psoriasis and other skin diseases. The biochemical and anti-inflammatory activity of 9-phenylnonanohydroxamic acid (BMY 30094) is described. BMY 30094 inhibited human neutrophil 5-lipoxygenase with an IC50 of 5.7 μM. BMY 30094 also blocked human platelet cyclooxygenase and lipoxygenase with IC50 values of 15.2 and 15.0 μM, respectively. Topical application of this compound blocked arachidonic acid and 12-O-tetradecanoylphorbol ester-induced mouse skin inflammation with activity comparable to that observed for lonapalene. The topical ED50 for BMY 30094 in the arachidonic acid-induced inflammation model is 2.2 μmoles/ear. In the sub-cutaneous carrageenan sponge assay in rats, BMY 30094 blocked LTB4 and PGE2 production and inhibited neutrophil migration. This compound would be a useful tool to determine the role of arachidonic acid metabolites in the etiology of inflammatory dermatoses.This publication has 30 references indexed in Scilit:
- Generation of the arachidonic acid metabolite 8-HETE by extracts of mouse skin treated with phorbol ester in vivo; identification by 1H-n.m.r. and GC-MS spectroscopyCarcinogenesis: Integrative Cancer Research, 1986
- Modulation of mouse ear edema by cyclooxygenase and lipoxygenase inhibitors and other pharmacologic agentsInflammation Research, 1985
- A dimethoxynaphthalene derivative (RS-43179 gel) compared with 0.025% fluocinolone acetonide gel in the treatment of psoriasisBritish Journal of Dermatology, 1985
- Inhibition of 12-O-Tetradecanoylphorbol-13-Acetate-lnduced Increase in Vascular Permeability in Mouse Skin by Lipoxygenase InhibitorsThe Japanese Journal of Pharmacology, 1985
- The Release of Leukotriene B4-like Material in Biologically Active Amounts from the Lesional Skin of patients with PsoriasisJournal of Investigative Dermatology, 1984
- The effects of BW755C and other anti-inflammatory drugs on eicosanoid concentrations and leukocyte accumulation in experimentally-induced acute inflammationJournal of Pharmacy and Pharmacology, 1983
- Local Effects of Synthetic Leukotrienes (LTC4, LTD4, and LTB4) in Human SkinJournal of Investigative Dermatology, 1983
- Arachidonic acid and prostaglandin E2 release and enhanced cell proliferation induced by the phorbol ester TPA in a murine epidermal cell lineCancer Letters, 1981
- Prostaglandin E and F levels in mouse epidermis are increased by tumor-promoting phorbol estersBiochemical and Biophysical Research Communications, 1979
- AN EXTENSION OF THE51Cr-RELEASE ASSAY FOR THE ESTIMATION OF MOUSE CYTOTOXINSTransplantation, 1968